Effectiveness of Aripiprazole Long-acting Injection in Recent Onset and Chronic Schizophrenia Patients

Effectiveness of Aripiprazole Long-acting Injection in Recent Onset and Chronic Schizophrenia Patients

The aim of the study is to investigate the effectiveness of Aripiprazole long-acting injection in recent onset and chronic schizophrenia patients

The aim of this study is to investigate the effectiveness of Aripiprazole long-acting injection in recent onset and chronic schizophrenia patients

Inclusion Criteria:

• Patients diagnosed with schizophrenia according to DSM-5 diagnostic standards
• men and women aged 19 and under 60
• a person who is being given an atypical antipsychotic.
• Patients should be able to reasonably cooperate with the questionnaire to be used for the study
• a person who fully understands the purpose of the study and signs the consent
• stable outpatient before screening without changing the volume of antipsychotics for at least two weeks

Exclusion Criteria:

• a person who has a serious and unstable physical condition either now or in the past
• A fertile woman who is currently pregnant or breastfeeding, or who is either unwilling or unable to use acceptable contraception until the clinical trial is complete.
• a person suffering from severe drug allergies or complex and severe drug reactions
• Patients who have taken clozapine in the last 60 days
• subjects showing significant risk of suicide or significant risk of violent behavior based on past history or investigator's judgment